Horan Capital Advisors’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $235K | Hold |
2,075
| – | – | 0.08% | 109 |
|
|
2024
Q4 | $219K | Hold |
2,075
| – | – | 0.07% | 107 |
|
|
2024
Q3 | $224K | Hold |
2,075
| – | – | 0.07% | 110 |
|
|
2024
Q2 | $225K | Hold |
2,075
| – | – | 0.08% | 104 |
|
|
2024
Q1 | $274K | Hold |
2,075
| – | – | 0.1% | 100 |
|
|
2023
Q4 | $253K | Sell |
2,075
-8
| -0.4% | -$974 | 0.09% | 104 |
|
|
2023
Q3 | $234K | Hold |
2,083
| – | – | 0.09% | 106 |
|
|
2023
Q2 | $303K | Hold |
2,083
| – | – | 0.12% | 85 |
|
|
2023
Q1 | $269K | Hold |
2,083
| – | – | 0.11% | 87 |
|
|
2022
Q4 | $266K | Hold |
2,083
| – | – | 0.12% | 84 |
|
|
2022
Q3 | $218K | Hold |
2,083
| – | – | 0.11% | 83 |
|
|
2022
Q2 | $219K | Hold |
2,083
| – | – | 0.1% | 84 |
|
|
2022
Q1 | $266K | Sell |
2,083
-62
| -3% | -$7.92K | 0.11% | 83 |
|
|
2021
Q4 | $265K | Hold |
2,145
| – | – | 0.11% | 82 |
|
|
2021
Q3 | $305K | Hold |
2,145
| – | – | 0.13% | 78 |
|
|
2021
Q2 | $335K | Hold |
2,145
| – | – | 0.15% | 70 |
|
|
2021
Q1 | $333K | Sell |
2,145
-309
| -13% | -$48K | 0.16% | 67 |
|
|
2020
Q4 | $367K | Sell |
2,454
-567
| -19% | -$84.8K | 0.19% | 64 |
|
|
2020
Q3 | $399K | Hold |
3,021
| – | – | 0.23% | 61 |
|
|
2020
Q2 | $350K | Sell |
3,021
-175
| -5% | -$20.3K | 0.23% | 57 |
|
|
2020
Q1 | $314K | Buy |
3,196
+2,786
| +680% | +$274K | 0.25% | 56 |
|
|
2019
Q4 | $60K | Hold |
410
| – | – | 0.04% | 138 |
|
|
2019
Q3 | $55K | Buy |
+410
| New | +$55K | 0.03% | 141 |
|
|
2019
Q2 | – | Sell |
-410
| Closed | -$51K | – | 256 |
|
|
2019
Q1 | $51K | Buy |
+410
| New | +$51K | 0.03% | 139 |
|
|
2017
Q4 | – | Sell |
-7
| Closed | -$1K | – | 292 |
|
|
2017
Q3 | $1K | Buy |
+7
| New | +$1K | ﹤0.01% | 313 |
|